Apr 1, 2020 by Brian Orelli, PhDFDA Asks for Recalls of Sanofi's Zantac and All Generic VersionsThe agency says there is a risk that some of the heartburn pills may contain unacceptable levels of NDMA, a possible carcinogen.
Mar 31, 2020 by Brian Orelli, PhDEli Lilly Licenses Immunology Drugs for Up to $880 MillionThe pharma giant will develop and market up to four drugs from the pipeline of privately-held Sitryx.
Mar 30, 2020 by Brian Orelli, PhDShares of Amarin Down 68% After Losing a Patent Lawsuit for VascepaJudge rules that the patents were obvious.
Mar 30, 2020 by Brian Orelli, PhDHere's Why Johnson & Johnson Jumped Higher TodayThe healthcare conglomerate has made substantial progress developing a vaccine for COVID-19.
Mar 30, 2020 by Brian Orelli, PhDCigna and Humana Join Aetna in Waiving COVID-19 Patients' Cost-Sharing PaymentsThe insurers could benefit from the move.
Mar 27, 2020 by Brian Orelli, PhDSanofi and Translate Bio Team Up to Work on a Coronavirus VaccineTranslate Bio's messenger RNA technology will make the development process faster than the traditional methods.
Mar 26, 2020 by Brian Orelli, PhDInovio Pharmaceuticals Reports Positive Trial Data for Cancer VaccineThe results from its study of VGX-3100 are an encouraging signal that the biotech's coronavirus vaccine might work too.
Mar 25, 2020 by Brian Orelli, PhDGilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19U.S. cases of COVID-19 may exceed the maximum for the designation.
Mar 25, 2020 by Brian Orelli, PhDFDA Facilitating Use of Plasma From Recovered COVID-19 Patients to Treat Serious CasesThe plasma of those who have recovered contains antibodies to the novel coronavirus, which could help other patients fight it off.
Mar 25, 2020 by Brian Orelli, PhDCVS Health's Aetna Insurance Waives Cost-Sharing and Co-Pays for COVID-19 TreatmentsThe company had already waived co-pays for SARS-CoV-2 tests and for telemedicine services.
Mar 23, 2020 by Brian Orelli, PhDRoche Tests Arthritis Drug Actemra for COVID-19 PneumoniaThe anti-inflammatory drug could help patients infected with the novel coronavirus.
Mar 23, 2020 by Brian Orelli, PhDCVS Giving Frontline Workers Bonuses, Hiring 50,000 to Meet COVID-19 NeedsThe coronavirus pandemic will require the pharmacy operator to staff up.
Mar 20, 2020 by Brian Orelli, PhDFDA Warns About Unauthorized Fraudulent COVID-19 TestsThe agency hasn't approved any in-home test kits yet.
Mar 20, 2020 by Brian Orelli, PhDAre Chloroquine and Hydrochloroquine Approved to Treat COVID-19?No, but doctors can still use the drugs despite limited evidence of their effectiveness.
Mar 20, 2020 by Brian Orelli, PhDTeva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 TreatmentPreliminary studies done in China suggest the decades-old malaria drug could inhibit the growth of the novel coronavirus.
Mar 20, 2020 by Brian Orelli, PhDFDA Relaxes Rules on Hand Sanitizer Producers Amid the Coronavirus PandemicBreweries, distilleries, and other companies will be able to help meet soaring demand if they follow the WHO's recipe.
Mar 19, 2020 by Brian Orelli, PhDMylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 TreatmentThe decades-old malaria drug could help fight the new coronavirus.
Mar 19, 2020 by Brian Orelli, PhDExact Sciences Withdraws Guidance, Shares Still Jump 32%The growth stock has become a value stock.
Mar 19, 2020 by Brian Orelli, PhDAbbvie's HIV Drug Kaletra Fails to Help COVID-19 PatientsA subset of patients improved faster, but further clinical trials are required to see if the results are real.
Mar 18, 2020 by Brian Orelli, PhDCoronavirus Test-makers Ramp Up ProductionMultiple companies have gained regulatory approvals in recent days.
